Carlsmed, Inc. (CARL)

Market Cap	363.01M
Revenue (ttm)	32.27M
Net Income (ttm)	-25.72M
Shares Out	26.52M
EPS (ttm)	-1.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	114,886
Open	14.11
Previous Close	13.90
Day's Range	13.35 - 14.16
52-Week Range	11.81 - 15.20
Beta	n/a
Analysts	Strong Buy
Price Target	18.33 (+33.89%)
Earnings Date	Aug 28, 2025

About CARL

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 2025
• Employees: 89
• Stock Exchange: NASDAQ
• Ticker Symbol: CARL
• Website: https://carlsmed.com

Financial Performance

Financial numbers in USD

Analyst Summary

According to 3 analysts, the average rating for CARL stock is "Strong Buy." The 12-month stock price target is $18.33, which is an increase of 33.89% from the latest price.

Price Target

$18.33

(33.89% upside)

Analyst Consensus: Strong Buy